Target's General Information
Target ID T58920
Target Name Thyrotropin-releasing hormone (TRH)
Synonyms Prothyroliberin; Pro-thyrotropin-releasing hormone; Pro-TRH
Target Type Clinical trial
Gene Name TRH
UniProt ID TRH_HUMAN
Target's Expression Profile in Disease Related Tissue between Patients and Normal People
Disease Parkinson's disease
Example drug KPS-0373 Phase 3 [1], [2], [3]
Tissue Substantia nigra tissue
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: 0.09
Z-score: 0.49
P-value: 2.52E-01
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Target's Expression Profile across Various Tissues of Healthy Individual
References
REF 1 ClinicalTrials.gov (NCT01970111) An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD). U.S. National Institutes of Health.
REF 2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
REF 3 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.